Compare SGI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGI | SNN |
|---|---|---|
| Founded | 1846 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 14.0B |
| IPO Year | N/A | 1999 |
| Metric | SGI | SNN |
|---|---|---|
| Price | $91.86 | $33.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $93.67 | $32.83 |
| AVG Volume (30 Days) | ★ 2.2M | 476.9K |
| Earning Date | 11-06-2025 | 03-02-2026 |
| Dividend Yield | 0.65% | ★ 2.19% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | ★ 1.58 | 0.56 |
| Revenue | ★ $6,816,000,000.00 | $5,944,000,000.00 |
| Revenue This Year | $54.31 | $7.78 |
| Revenue Next Year | $6.43 | $5.13 |
| P/E Ratio | $58.22 | ★ $29.10 |
| Revenue Growth | ★ 39.29 | 5.35 |
| 52 Week Low | $53.10 | $23.69 |
| 52 Week High | $94.42 | $38.79 |
| Indicator | SGI | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 60.19 | 48.01 |
| Support Level | $89.84 | $32.68 |
| Resistance Level | $94.42 | $33.56 |
| Average True Range (ATR) | 2.67 | 0.41 |
| MACD | 0.23 | 0.14 |
| Stochastic Oscillator | 76.30 | 78.51 |
Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses, Tempur Sealy, Mattress Firm and Dreams. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.